Menu Close

Current Research & Developments Status of Chimeric Antigen Receptor (CAR) T-Cell Therapy: 2017-2018 to 2023 –

and details of patent expirations Determine the production methods for CAR T-cells Review the range of joint ventures, collaborations, license and research agreements currently focused on CAR T-cell technology Review of the regulatory requirements Review … (본문 전체 8/8/2018 12:23 AM)